|Articles|October 1, 2011
Ocriplasmin treats sVMA
Approach achieves positive results in trials
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: New horizons in research and risk management for ROP
2
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
5









































